This technology is a novel bio-marker diagnostic for use with patients who are undergoing invasive cardiac procedures as a predictive tool to guide enteral nutrition.

About

Diagnostic for Gastrointestinal Dysfunction

Case ID: UA14-143

Invention:
This technology is a novel bio-marker diagnostic for use in conjunction with patients who are undergoing invasive cardiac procedures as a predictive tool to guide initiation, advancement, or withdrawal of enteral nutrition during these cardiac events. This technology allows non-invasive assessment of intestinal barrier function to guide safe and optimized enteral nutrition delivery.

Background:
Children undergoing cardiopulmonary bypass for repair or palliation of congestive heart disease are at risk for intestinal injury and often present with altered intestinal barrier function. Monitoring markers of intestinal injury may lead to innovative pre- and post-operative gut-protective measures during various illness states.

Stage of development:
This technology is undergoing continued research and refinement.

Key Benefits

Non-invasive

Applications

Objective diagnostic predictor tool that will optimize safe delivery of enteral nutrition.
Reduction in sepsis and hospital-acquired infections.

Purchase a license for full unlimited access to all innovation profiles on LEO

  • Direct connection to thousands of more innovations
  • Access to market Experts and Universities
  • Filter relevant solutions into your own dedicated Network